accelerated cytotoxicity mechanism screening
Authors
abstract
by discovering how chemical compounds/xenobiotics cytotoxicity is affected when their metabolic pathways are inhibited or activated, the metabolic pathways that activate versus detoxify chemical compound can be identified. reactive metabolites contributing to cytotoxicity can also be identified. in this lecture, the pretreatment of inhibitors and activators of xenobiotic metabolizing enzymes as well as other xenobiotic cellular targets in freshly isolated rat hepatocytes for the accelerated cytotoxicity mechanism screening (acms) of xenobiotics (a technique used in our laboratory) are discussed. this technique is useful for determining toxicity mechanisms. the inhibitors/ activators have been selected on the basis of their selectivity, modulator effectiveness, and their lack of toxicity. the use of these inhibitors/activators with other cells or subcellular fractions (e.g. mitochondria) for assessing target organ toxicity mechanisms is also reviewed.
similar resources
Accelerated Cytotoxicity Mechanism Screening
By discovering how chemical compounds/xenobiotics cytotoxicity is affected when their metabolic pathways are inhibited or activated, the metabolic pathways that activate versus detoxify chemical compound can be identified. Reactive metabolites contributing to cytotoxicity can also be identified. In this lecture, the pretreatment of inhibitors and activators of xenobiotic metabolizing enzymes as...
full textToxicity Evaluation of 6-Mercaptopurine Using Accelerated Cytotoxicity Mechanism Screening (ACMS) techniques
6- Mercaptopurine (6-MP) is widely used in clinic as an immunosuppressive for treatment of acute lymphocytic leukemia, Crohn's disease, and ulcerative colitis with documented unpredictable hepatotoxicity. The potential molecular cytotoxic mechanisms of 6-MP against isolated rat hepatocytes were searched in this study using “Accelerated Cytotoxicity Mechanism Screening (ACMS)” techniques. The co...
full texttoxicity evaluation of 6-mercaptopurine using accelerated cytotoxicity mechanism screening (acms) techniques
6- mercaptopurine (6-mp) is widely used in clinic as an immunosuppressive for treatment of acute lymphocytic leukemia, crohn's disease, and ulcerative colitis with documented unpredictable hepatotoxicity. the potential molecular cytotoxic mechanisms of 6-mp against isolated rat hepatocytes were searched in this study using “accelerated cytotoxicity mechanism screening (acms)” techniques. t...
full textMechanism of ribonuclease cytotoxicity.
Bovine seminal ribonuclease (BS-RNase), a dimeric homolog of bovine pancreatic ribonuclease A (RNase A), is toxic to mammalian cells. In contrast to dimeric BS-RNase, a monomeric BS-RNase and RNase A are not cytotoxic and are bound tightly by cytosolic ribonuclease inhibitor. To elucidate the mechanism of ribonuclease cytotoxicity, we constructed a series of hybrid and semisynthetic enzymes and...
full textMaterials Screening Through GPU Accelerated Topological Mapping
depiction of complex void space topology of nano-porous materials. Journal of Chemical Information and Model-ing 2010, 50 (4), 461–469. 20. Oganov, A.R., Ed. Modern Methods of Crystal StructurePrediction. Wiley-VCH: Weinheim, Germany, 2010.21. Ciobanu, C.V.; Wang, C.-Z.; Ho, K.-M. Atomic StructurePrediction of Nanostructures, Clusters, and Surfaces. Wiley-VCH: Weinheim, Germ...
full textEvaluation of cytotoxicity mechanism of two cyclo-oxygenase-2 inhibitors in leukemia cell line
Introduction: Leukemia is considered one of the main causes of death, and current chemotherapeutic agents are unable to provide optimal responses due to chemo-resistance. Therefore, there is a constant need for new drugs. Cyclooxygenase- 2 (COX-2) inhibitors can be helpful by reducing the necessary dose of routine chemotherapeutic drugs. Herein, we evaluated the cytotoxicity activity as well...
full textMy Resources
Save resource for easier access later
Journal title:
asia pacific journal of medical toxicologyجلد ۳، شماره Supplement ۱، صفحات ۴-۴
Keywords
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023